BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Zephyr AI Appoints Dr. Lisa Eli as Chief Scientific Officer

  April 21, 2026

   · 

  2 min read
• Press Releases

  Omeza announces closing of $8.5 Million Series A financing co-led by Astanor and BluKap Ventures, with participation from Catalyst Investments

  Round positions Omeza to accelerate clinical development and scale nationwide commercialization of its FDA-cleared regenerative wound care platform

  April 21, 2026

   · 

  1 min read
• Press Releases

  PharmaTher Highlights Strategic Ketamine Opportunity Following New U.S. Executive Order on Psychedelic Treatments for Serious Mental Illness

  Company believes supportive U.S. policy momentum may strengthen the strategic value of its ketamine patch, KetaVault™ platform, retained ketamine programs, and prior FDA-approved ketamine ANDA transaction

  April 21, 2026

   · 

  1 min read
• Press Releases

  Virica Biotech Introduces Viric.AI, an Active Learning Platform to Accelerate Biomanufacturing Optimization

  April 21, 2026

   · 

  3 min read
• Press Releases

  Microbiome Labs relaunches BiomeFX to advance gut microbiome interpretation

  Powered by Jona’s clinical-grade, AI-powered microbiome analysis.

  April 21, 2026

   · 

  3 min read
• Press Releases

  Biospecimen Procurement Market to Reach USD 207.40 Million in 2035, Rising at a 8.60%

  April 21, 2026

   · 

  1 min read
• Press Releases

  Allogeneic Cell Therapy Market Hit USD 5968.77 Million by 2035

  April 21, 2026

   · 

  1 min read
• Press Releases

  Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression

  April 21, 2026

   · 

  8 min read
• Press Releases

  Star Therapeutics Receives FDA Rare Pediatric Disease and Breakthrough Therapy Designations for VGA039 in Von Willebrand Disease Prophylaxis

  April 21, 2026

   · 

  4 min read
• Press Releases

  Tortugas Neuroscience Launches with $106 Million to Advance Clinical Stage Pipeline Targeting New and Major Neurology and Neuropsychiatric Disorders

  April 21, 2026

   · 

  4 min read